Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Maertens

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 22, 2008
Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implicationsMário G Pessôa, Venancio A F Alves, Alda Wakamatsu, et al.
Journal of Translational Medicine|April 21, 2016
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitorsMax Schreuer, Geert Meersseman, Sari Van Den Herrewegen, et al.
Journal of Virology|February 28, 2006
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virusYves Rouillé, François Helle, David Delgrange, et al.
Hepatology (Baltimore, Md.)|October 28, 2003
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CFrederik Nevens, Tania Roskams, Hans Van Vlierberghe, et al.
Plos One|August 27, 2013
Comparison of pathogen DNA isolation methods from large volumes of whole blood to improve molecular diagnosis of bloodstream infectionsAnne J M Loonen, Martine P Bos, Bart van Meerbergen, et al.
The Journal of Infectious Diseases|August 19, 2011
Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodiesBabs E Verstrepen, Erik Depla, Christine S Rollier, et al.
Journal of Virology|August 17, 2004
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis CDaniel Steinmann, Heidi Barth, Bettina Gissler, et al.
Hepatology (Baltimore, Md.)|September 9, 2005
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypesPeter Simmonds, Jens Bukh, Christophe Combet, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|April 22, 2008
Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implicationsMário G Pessôa, Venancio A F Alves, Alda Wakamatsu, et al.
Journal of Translational Medicine|April 21, 2016
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitorsMax Schreuer, Geert Meersseman, Sari Van Den Herrewegen, et al.
Journal of Virology|February 28, 2006
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virusYves Rouillé, François Helle, David Delgrange, et al.
Hepatology (Baltimore, Md.)|October 28, 2003
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CFrederik Nevens, Tania Roskams, Hans Van Vlierberghe, et al.
Plos One|August 27, 2013
Comparison of pathogen DNA isolation methods from large volumes of whole blood to improve molecular diagnosis of bloodstream infectionsAnne J M Loonen, Martine P Bos, Bart van Meerbergen, et al.
The Journal of Infectious Diseases|August 19, 2011
Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodiesBabs E Verstrepen, Erik Depla, Christine S Rollier, et al.
Journal of Virology|August 17, 2004
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis CDaniel Steinmann, Heidi Barth, Bettina Gissler, et al.
Hepatology (Baltimore, Md.)|September 9, 2005
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypesPeter Simmonds, Jens Bukh, Christophe Combet, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.
Pageof 3